Showing results (91-100 of 101) with videos related to
Sort By:
Pageof 11
Transplantation|October 12, 2013
Functional status and survival after kidney transplantationPeter P Reese, Roy D Bloom, Justine Shults, et al.Plastic and Reconstructive Surgery|December 28, 2017
The Public Face of Transplantation: The Potential of Education to Expand the Face Donor PoolNatalie M Plana, Laura L Kimberly, Brendan Parent, et al.SAGE Open Medicine|August 7, 2019
Evolving ethics, policy and reimbursement issues of vascularized composite allotransplantation: Symposium summaryJohn Rose, Carisa M Cooney, Christina Kaufman, et al.Nature Reviews. Neuroscience|December 3, 2009
Neurotalk: improving the communication of neuroscience researchJudy Illes, Mary Anne Moser, Jennifer B McCormick, et al.Vaccine|September 24, 2024
Social complexity of a fentanyl vaccine to prevent opioid overdose conference proceedings: Radcliffe Institute for Advanced Study conference proceedingsElissa R Weitzman, , Margarita Alegria, et al.Journal of Medical Ethics|December 10, 2023
Research involving the recently deceased: ethics questions that must be answeredBrendan Parent, Olivia S Kates, Wadih Arap, et al.Transplantation|April 30, 2011
Longer-term outcomes after kidney transplantation from seronegative deceased donors at increased risk for blood-borne viral infectionPeter P Reese, Scott D Halpern, David A Asch, et al.Vaccine|April 29, 2014
Placebo use in vaccine trials: recommendations of a WHO expert panelAnnette Rid, Abha Saxena, Abdhullah H Baqui, et al.Lancet (London, England)|November 18, 2021
Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USASaad B Omer, Regina M Benjamin, Noel T Brewer, et al.Archives of General Psychiatry|March 7, 2002
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disordersDennis S Charney, Charles B Nemeroff, Lydia Lewis, et al.Pageof 11